Tactile Systems Technology Inc
NASDAQ:TCMD

Watchlist Manager
Tactile Systems Technology Inc Logo
Tactile Systems Technology Inc
NASDAQ:TCMD
Watchlist
Price: 18.33 USD -3.12% Market Closed
Market Cap: 439.9m USD
Have any thoughts about
Tactile Systems Technology Inc?
Write Note

Tactile Systems Technology Inc
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tactile Systems Technology Inc
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Tactile Systems Technology Inc
NASDAQ:TCMD
Other Long-Term Assets
$22.9m
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Other Long-Term Assets
$2.6B
CAGR 3-Years
10%
CAGR 5-Years
19%
CAGR 10-Years
18%
Boston Scientific Corp
NYSE:BSX
Other Long-Term Assets
$4.5B
CAGR 3-Years
-1%
CAGR 5-Years
19%
CAGR 10-Years
28%
Stryker Corp
NYSE:SYK
Other Long-Term Assets
$3.9B
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
18%
Abbott Laboratories
NYSE:ABT
Other Long-Term Assets
$7.7B
CAGR 3-Years
24%
CAGR 5-Years
27%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Other Long-Term Assets
$1.6B
CAGR 3-Years
21%
CAGR 5-Years
17%
CAGR 10-Years
28%
No Stocks Found

Tactile Systems Technology Inc
Glance View

Market Cap
439.3m USD
Industry
Health Care

Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.

TCMD Intrinsic Value
21.22 USD
Undervaluation 14%
Intrinsic Value
Price

See Also

What is Tactile Systems Technology Inc's Other Long-Term Assets?
Other Long-Term Assets
22.9m USD

Based on the financial report for Jun 30, 2024, Tactile Systems Technology Inc's Other Long-Term Assets amounts to 22.9m USD.

What is Tactile Systems Technology Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
14%

Over the last year, the Other Long-Term Assets growth was 595%. The average annual Other Long-Term Assets growth rates for Tactile Systems Technology Inc have been 13% over the past three years , 14% over the past five years .

Back to Top